Analysis: Time for Cyberonics to Improve
FOX News - CHICAGO — Recent months have been eventful and largely rough for Cyberonics Inc., including news the medical-device company is unlikely to win Medicare reimbursement approval for its depression-treatment system. That follows probes over stock
Source: www.foxnews.com
Duloxetine Has Less Effect on Male Sexual Function Than Escitalopram
Medscape News - NEW YORK (Reuters Health) May 24 - Among men with major depression, treatment with duloxetine (Cymbalta) is associated with less worsening of sexual function than is escitalopram (Lexapro), investigators reported this week at the American Psychiatric
Source: www.medscape.com
Click here for more information about women and depression women and depression
<< Home